Insights from BCC Research

Biomarkers: Advancing Drug Development, Dominating the Market

Posted by Sarah Gallo on Dec 10, 2018 11:00:00 AM

Biomarkers

Biomarkers are at the core of identifying any disease or biological condition, and the discovery of new biomarkers has enormous commercial potential. While aiding in diagnostics, prognostics and companion diagnostics, biomarkers are becoming essential tools in one critical process: drug development. As a result, the biomarkers market has been rapidly expanding in recent years, according to a recent webinar led by BCC Research analyst Marianna Tcherpakov, PhD.

Read More

Topics: Biotechnology, Life Sciences

An Introduction to Biomarkers

Posted by BCC Research Staff Analysts on Sep 3, 2018 11:00:00 AM

Biomarkers_Image

Read More

Topics: Biotechnology, Life Sciences

What is Synthetic Biology?

Posted by John Bergin on Jul 13, 2018 10:00:00 AM

Synthetic_BiologyThe following is an excerpt from BCC Research Report “Synthetic Biology: Global Markets” by John Bergin.

Read More

Topics: Biotechnology, Life Sciences

Patent Cliff Paves the Way for Biosimilars to Disrupt Market

Posted by Jeff Schmerker on Mar 26, 2018 10:30:00 AM

Biological SafetyTesting.jpgThe global market for biological safety testing is anticipating brisk growth in coming years owing to the growth of personalized medicines, patent expiration of brand-name biologics, and the development of new cell lines that express specific biomarkers for disease states, according to a new report from BCC Research. The market’s compound annual growth rate (CAGR) is forecast to be 20.09% through 2022.

Read More

Topics: Biotechnology, Life Sciences